Trial Profile
Randomized, Double-Blind, Vehicle-Controlled, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2017
Price :
$35
*
At a glance
- Drugs Dapansutrile (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Olatec Therapeutics
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2013 Planned number of patients changed from 66 to 84 as reported by ClinicalTrials.gov.
- 01 May 2013 Planned End Date changed from 1 Jun 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.